Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

Overview of attention for article published in American Heart Journal, February 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 6 X users

patent: 13 patents
guideline: 1 clinical guideline source

Readers on

mendeley: 266 Mendeley

So far, Altmetric has seen 8 X posts from 6 X users, with an upper bound of 63,206 followers.

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a… http://t.co/BXTN8aQ32f

#TECOS countdown 33 hrs #ADA2015 Pt characteristics Age 66, BMI 30, A1C 7.3 h/o MI 43% CHF 18%http://t.co/StTKL6nVEi http://t.co/FUlnUd1lpb

ELIXA Discussion on initial results of 6,000 type 2 DM pts who experienced an acute coronary event #ada2015 #diabetes http://t.co/tHJXAVQYrX

#TECOS countdown 33 hrs #ADA2015 Pt characteristics Age 66, BMI 30, A1C 7.3 h/o MI 43% CHF 18%http://t.co/StTKL6nVEi http://t.co/FUlnUd1lpb

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.